Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations of these. This portion of the NCCN Guidelines discusses recommendations specific to the locoregional management of clinical stage I, II, and IIIA (T3N1M0) tumors.

  • 1.

    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:529.

  • 2.

    Forouzanfar MH, Foreman KJ, Delossantos AM. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011;6736:6135161352.

    • Search Google Scholar
    • Export Citation
  • 3.

    DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin 2014;64:5262.

  • 4.

    Early Breast Cancer Trialists> Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:16871717.

    • Search Google Scholar
    • Export Citation
  • 5.

    Berry DA, Cronin KA, Plevritis SK. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:17841792.

    • Search Google Scholar
    • Export Citation
  • 6.

    Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med 2002;137:678687.

  • 7.

    Giordano SH, Valero V, Buzdar AU, Hortobagyi GN. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol 2002;25:235237.

  • 8.

    Esserman L. Integration of imaging in the management of breast cancer. J Clin Oncol 2005;23:16011602.

  • 9.

    Gundry KR. The application of breast MRI in staging and screening for breast cancer. Oncology (Williston Park) 2005;19:159169.

  • 10.

    Houssami N, Ciatto S, Macaskill P. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008;26:32483258.

    • Search Google Scholar
    • Export Citation
  • 11.

    Miller BT, Abbott AM, Tuttle TM. The influence of preoperative MRI on breast cancer treatment. Ann Surg Oncol 2012;19:536540.

  • 12.

    Peters NH, van Esser S, van den Bosch MA. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer 2011;47:879886.

    • Search Google Scholar
    • Export Citation
  • 13.

    Turnbull LW, Brown SR, Olivier C. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess 2010;14:1182.

    • Search Google Scholar
    • Export Citation
  • 14.

    Fischer U, Zachariae O, Baum F. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004;14:17251731.

    • Search Google Scholar
    • Export Citation
  • 15.

    Solin LJ, Orel SG, Hwang WT. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008;26:386391.

    • Search Google Scholar
    • Export Citation
  • 16.

    White J, Morrow M, Moughan J. Compliance with breast-conservation standards for patients with early-stage breast carcinoma. Cancer 2003;97:893904.

    • Search Google Scholar
    • Export Citation
  • 17.

    Wilkinson NW, Shahryarinejad A, Winston JS. Concordance with breast cancer pathology reporting practice guidelines. J Am Coll Surg 2003;196:3843.

    • Search Google Scholar
    • Export Citation
  • 18.

    Baucom DH, Porter LS, Kirby JS. Psychosocial issues confronting young women with breast cancer. Breast Dis 2005;23:103113.

  • 19.

    Dunn J, Steginga SK. Young women’s experience of breast cancer: defining young and identifying concerns. Psychooncology 2000;9:137146.

  • 20.

    Ganz PA, Greendale GA, Petersen L. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 2003;21:41844193.

    • Search Google Scholar
    • Export Citation
  • 21.

    Gorman JR, Bailey S, Pierce JP, Su HI. How do you feel about fertility and parenthood? The voices of young female cancer survivors. J Cancer Surviv 2012;6:200209.

    • Search Google Scholar
    • Export Citation
  • 22.

    Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst 2012;104:386405.

    • Search Google Scholar
    • Export Citation
  • 23.

    Kranick JA, Schaefer C, Rowell S. Is pregnancy after breast cancer safe? Breast J 2010;16:404411.

  • 24.

    Cruz MR, Prestes JC, Gimenes DL, Fanelli MF. Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review. Fertil Steril 2010;94:138143.

    • Search Google Scholar
    • Export Citation
  • 25.

    Dunn L, Fox KR. Techniques for fertility preservation in patients with breast cancer. Curr Opin Obstet Gynecol 2009;21:6873.

  • 26.

    Oktem O, Oktay K. Fertility preservation for breast cancer patients. Semin Reprod Med 2009;27:486492.

  • 27.

    Redig AJ, Brannigan R, Stryker SJ. Incorporating fertility preservation into the care of young oncology patients. Cancer 2011;117:410.

  • 28.

    Lee S, Ozkavukcu S, Heytens E. Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol 2010;28:46834686.

    • Search Google Scholar
    • Export Citation
  • 29.

    Lobo RA. Potential options for preservation of fertility in women. N Engl J Med 2005;353:6473.

  • 30.

    Sukumvanich P, Case LD, Van Zee K. Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer 2010;116:31023111.

    • Search Google Scholar
    • Export Citation
  • 31.

    Peate M, Meiser B, Friedlander M. It’s now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer—an Australian fertility decision aid collaborative group study. J Clin Oncol 2011;29:16701677.

    • Search Google Scholar
    • Export Citation
  • 32.

    Members of the Breast Cancer Disease Site Group. Baseline staging tests in primary breast cancer. Available at: http://www.cancercare.on.ca/common/pages/UserFile.aspx?serverId=6&path=/File%20Database/CCO%20Files/PEBC/pebc1-14f.pdf. Accessed March 1, 2014.

    • Search Google Scholar
    • Export Citation
  • 33.

    Puglisi F, Follador A, Minisini AM. Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications. Ann Oncol 2005;16:263266.

    • Search Google Scholar
    • Export Citation
  • 34.

    Kumar R, Chauhan A, Zhuang H. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat 2006;98:267274.

    • Search Google Scholar
    • Export Citation
  • 35.

    Podoloff DA, Advani RH, Allred C. NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw 2007;5(Suppl 1):11.

    • Search Google Scholar
    • Export Citation
  • 36.

    Rosen EL, Eubank WB, Mankoff DA. FDG PET, PET/CT, and breast cancer imaging. Radiographics 2007;27(Suppl 1):S215229.

  • 37.

    Wahl RL, Siegel BA, Coleman RE, Gatsonis CG. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group. J Clin Oncol 2004;22:277285.

    • Search Google Scholar
    • Export Citation
  • 38.

    Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996;14:15581564.

    • Search Google Scholar
    • Export Citation
  • 39.

    Clarke M, Collins R, Darby S. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:20872106.

    • Search Google Scholar
    • Export Citation
  • 40.

    Fisher B, Anderson S, Bryant J. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:12331241.

    • Search Google Scholar
    • Export Citation
  • 41.

    Veronesi U, Cascinelli N, Mariani L. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:12271232.

    • Search Google Scholar
    • Export Citation
  • 42.

    Early Breast Cancer Trialists’ Collaborative G Darby S, McGale P. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011;378:17071716.

    • Search Google Scholar
    • Export Citation
  • 43.

    Moran MS, Schnitt SJ, Giuliano AE. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol 2014;32:15071515.

    • Search Google Scholar
    • Export Citation
  • 44.

    Fourquet A, Campana F, Zafrani B. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989;17:719725.

    • Search Google Scholar
    • Export Citation
  • 45.

    Komoike Y, Akiyama F, Iino Y. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer 2006;106:3541.

    • Search Google Scholar
    • Export Citation
  • 46.

    Zhou P, Gautam S, Recht A. Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat 2007;101:5157.

    • Search Google Scholar
    • Export Citation
  • 47.

    Golshan M, Miron A, Nixon AJ. The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy. Am J Surg 2006;192:5862.

    • Search Google Scholar
    • Export Citation
  • 48.

    Kroman N, Holtveg H, Wohlfahrt J. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer 2004;100:688693.

    • Search Google Scholar
    • Export Citation
  • 49.

    Recht A. Contralateral prophylactic mastectomy: caveat emptor. J Clin Oncol 2009;27:13471349.

  • 50.

    Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst 2010;102:401409.

    • Search Google Scholar
    • Export Citation
  • 51.

    Jatoi I, Parsons HM. Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias. Breast Cancer Res Treat 2014;148:389396.

    • Search Google Scholar
    • Export Citation
  • 52.

    Portschy PR, Kuntz KM, Tuttle TM. Survival outcomes after contralateral prophylactic mastectomy: a decision analysis. J Natl Cancer Inst 2014;106.

    • Search Google Scholar
    • Export Citation
  • 53.

    Fayanju OM, Stoll CR, Fowler S. Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis. Ann Surg 2014;260:10001010.

    • Search Google Scholar
    • Export Citation
  • 54.

    Bass SS, Lyman GH, McCann CR. Lymphatic mapping and sentinel lymph node biopsy. Breast J 1999;5:288295.

  • 55.

    Cox CE. Lymphatic mapping in breast cancer: combination technique. Ann Surg Oncol 2001;8:67S70S.

  • 56.

    Cox CE, Nguyen K, Gray RJ. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001;67:513519.

  • 57.

    Krag D, Weaver D, Ashikaga T. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med 1998;339:941946.

  • 58.

    Krag DN, Anderson SJ, Julian TB. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11:927933.

    • Search Google Scholar
    • Export Citation
  • 59.

    Kuehn T, Vogl FD, Helms G. Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur J Surg Oncol 2004;30:252259.

    • Search Google Scholar
    • Export Citation
  • 60.

    Lyman GH, Giuliano AE, Somerfield MR. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:77037720.

    • Search Google Scholar
    • Export Citation
  • 61.

    McMasters KM, Giuliano AE, Ross MI. Sentinel-lymph-node biopsy for breast cancer—not yet the standard of care. N Engl J Med 1998;339:990995.

    • Search Google Scholar
    • Export Citation
  • 62.

    O’Hea BJ, Hill AD, El-Shirbiny AM. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423427.

    • Search Google Scholar
    • Export Citation
  • 63.

    Veronesi U, Paganelli G, Viale G. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546553.

    • Search Google Scholar
    • Export Citation
  • 64.

    Mansel RE, Fallowfield L, Kissin M. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98:599609.

    • Search Google Scholar
    • Export Citation
  • 65.

    Cox CE, Salud CJ, Cantor A. Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg 2001;193:593600.

    • Search Google Scholar
    • Export Citation
  • 66.

    Dupont E, Cox C, Shivers S. Learning curves and breast cancer lymphatic mapping: institutional volume index. J Surg Res 2001;97:9296.

  • 67.

    Giuliano AE, Hawes D, Ballman KV. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 2011;306:385393.

    • Search Google Scholar
    • Export Citation
  • 68.

    Degnim AC, Reynolds C, Pantvaidya G. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 2005;190:543550.

    • Search Google Scholar
    • Export Citation
  • 69.

    Houvenaeghel G, Nos C, Giard S. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol 2009;35:690695.

    • Search Google Scholar
    • Export Citation
  • 70.

    Katz A, Smith BL, Golshan M. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 2008;26:20932098.

    • Search Google Scholar
    • Export Citation
  • 71.

    Kohrt HE, Olshen RA, Bermas HR. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 2008;8:66.

    • Search Google Scholar
    • Export Citation
  • 72.

    Scow JS, Degnim AC, Hoskin TL. Assessment of the performance of the Stanford Online Calculator for the prediction of nonsentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients. Cancer 2009;115:40644070.

    • Search Google Scholar
    • Export Citation
  • 73.

    van la Parra RFD, Ernst MF, Bevilacqua JLB. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram. Ann Surg Oncol 2009;16:11281135.

    • Search Google Scholar
    • Export Citation
  • 74.

    Werkoff G, Lambaudie E, Fondrinier E. Prospective multicenter comparison of models to predict four or more involved axillary lymph nodes in patients with breast cancer with one to three metastatic sentinel lymph nodes. J Clin Oncol 2009;27:57075712.

    • Search Google Scholar
    • Export Citation
  • 75.

    Giuliano AE, McCall L, Beitsch P. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 2010;252:426432; discussion 432-423.

    • Search Google Scholar
    • Export Citation
  • 76.

    Giuliano AE, Hunt KK, Ballman KV. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305:569575.

    • Search Google Scholar
    • Export Citation
  • 77.

    Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer 1992;28A:14151418.

    • Search Google Scholar
    • Export Citation
  • 78.

    Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992;69:24962501.

    • Search Google Scholar
    • Export Citation
  • 79.

    Fisher B, Redmond C, Fisher ER. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674681.

    • Search Google Scholar
    • Export Citation
  • 80.

    Antonini N, Jones H, Horiot JC. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol 2007;82:265271.

    • Search Google Scholar
    • Export Citation
  • 81.

    Bartelink H, Horiot JC, Poortmans P. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345:13781387.

    • Search Google Scholar
    • Export Citation
  • 82.

    Pignol JP, Olivotto I, Rakovitch E. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008;26:20852092.

    • Search Google Scholar
    • Export Citation
  • 83.

    Mukesh MB, Barnett GC, Wilkinson JS. Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. J Clin Oncol 2013;31:44884495.

    • Search Google Scholar
    • Export Citation
  • 84.

    Mulliez T, Veldeman L, van Greveling A. Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions. Radiother Oncol 2013;108:203208.

    • Search Google Scholar
    • Export Citation
  • 85.

    Group ST, Bentzen SM, Agrawal RK. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008;371:10981107.

    • Search Google Scholar
    • Export Citation
  • 86.

    Group ST, Bentzen SM, Agrawal RK. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008;9:331341.

    • Search Google Scholar
    • Export Citation
  • 87.

    Owen JR, Ashton A, Bliss JM. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006;7:467471.

    • Search Google Scholar
    • Export Citation
  • 88.

    Whelan TJ, Pignol JP, Levine MN. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362:513520.

  • 89.

    Haviland JS, Owen JR, Dewar JA. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 2013;14:10861094.

    • Search Google Scholar
    • Export Citation
  • 90.

    Werkhoven E, Hart G, Tinteren H. Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial. Radiother Oncol 2011;100:101107.

    • Search Google Scholar
    • Export Citation
  • 91.

    Whelan TJ, Olivotto I, Ackerman I. NCIC-CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer [abstract]. J Clin Oncol 2011;29 (18_suppl):LBA1003.

    • Search Google Scholar
    • Export Citation
  • 92.

    McCormick B. Partial-breast radiation for early staged breast cancers: hypothesis, existing data, and a planned phase III trial. J Natl Compr Canc Netw 2005;3:301307.

    • Search Google Scholar
    • Export Citation
  • 93.

    Smith BD, Arthur DW, Buchholz TA. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009;74:9871001.

    • Search Google Scholar
    • Export Citation
  • 94.

    Shaitelman SF, Vicini FA, Beitsch P. Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry Trial. Cancer 2010;116:46774685.

    • Search Google Scholar
    • Export Citation
  • 95.

    Vicini F, Arthur D, Wazer D. Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2011;79:977984.

    • Search Google Scholar
    • Export Citation
  • 96.

    Bellon JR, Come SE, Gelman RS. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol 2005;23:19341940.

    • Search Google Scholar
    • Export Citation
  • 97.

    Recht A, Come SE, Henderson IC. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 1996;334:13561361.

    • Search Google Scholar
    • Export Citation
  • 98.

    Jones HA, Antonini N, Hart AA. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J Clin Oncol 2009;27:49394947.

    • Search Google Scholar
    • Export Citation
  • 99.

    Hughes KS, Schnaper LA, Berry D. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971977.

    • Search Google Scholar
    • Export Citation
  • 100.

    Hughes KS, Schnaper LA, Bellon JR. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 2013;31:23822387.

    • Search Google Scholar
    • Export Citation
  • 101.

    Fyles AW, McCready DR, Manchul LA. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004;351:963970.

    • Search Google Scholar
    • Export Citation
  • 102.

    Hellman S. Stopping metastases at their source. N Engl J Med 1997;337:996997.

  • 103.

    Overgaard M, Hansen PS, Overgaard J. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949955.

    • Search Google Scholar
    • Export Citation
  • 104.

    Overgaard M, Jensen MB, Overgaard J. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:16411648.

    • Search Google Scholar
    • Export Citation
  • 105.

    Ragaz J, Olivotto IA, Spinelli JJ. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005;97:116126.

    • Search Google Scholar
    • Export Citation
  • 106.

    Recht A, Edge SB, Solin LJ. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:15391569.

    • Search Google Scholar
    • Export Citation
  • 107.

    Huang EH, Tucker SL, Strom EA. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 2004;22:46914699.

    • Search Google Scholar
    • Export Citation
  • 108.

    McGuire SE, Gonzalez-Angulo AM, Huang EH. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 2007;68:10041009.

    • Search Google Scholar
    • Export Citation
  • 109.

    Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 2007;82:247253.

    • Search Google Scholar
    • Export Citation
  • 110.

    Early Breast Cancer Trialists’ Collaborative G McGale P, Taylor C. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014;383:21272135.

    • Search Google Scholar
    • Export Citation
  • 111.

    Nielsen HM, Overgaard M, Grau C. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 2006;24:22682275.

    • Search Google Scholar
    • Export Citation
  • 112.

    Jagsi R, Raad RA, Goldberg S. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys 2005;62:10351039.

    • Search Google Scholar
    • Export Citation
  • 113.

    Abdulkarim BS, Cuartero J, Hanson J. Increased risk of locoregional recurrence for women With T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. J Clin Oncol 2011;29:28522858.

    • Search Google Scholar
    • Export Citation
  • 114.

    Liu AS, Kao HK, Reish RG. Postoperative complications in prosthesis-based breast reconstruction using acellular dermal matrix. Plast Reconstr Surg 2011;127:17551762.

    • Search Google Scholar
    • Export Citation
  • 115.

    McCarthy CM, Mehrara BJ, Riedel E. Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 2008;121:18861892.

    • Search Google Scholar
    • Export Citation
  • 116.

    Cowen D, Gross E, Rouannet P. Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications. Breast Cancer Res Treat 2010;121:627634.

    • Search Google Scholar
    • Export Citation
  • 117.

    Woerdeman LA, Hage JJ, Hofland MM, Rutgers EJ. A prospective assessment of surgical risk factors in 400 cases of skin-sparing mastectomy and immediate breast reconstruction with implants to establish selection criteria. Plast Reconstr Surg 2007;119:455463.

    • Search Google Scholar
    • Export Citation
  • 118.

    Antony AK, McCarthy CM, Cordeiro PG. Acellular human dermis implantation in 153 immediate two-stage tissue expander breast reconstructions: determining the incidence and significant predictors of complications. Plast Reconstr Surg 2010;125:16061614.

    • Search Google Scholar
    • Export Citation
  • 119.

    Ahmed S, Snelling A, Bains M, Whitworth IH. Breast reconstruction. BMJ 2005;330:943948.

  • 120.

    Edlich RF, Winters KL, Faulkner BC. Advances in breast reconstruction after mastectomy. J Long Term Eff Med Implants 2005;15:197207.

  • 121.

    Pennington DG. Breast reconstruction after mastectomy: current state of the art. ANZ J Surg 2005;75:454458.

  • 122.

    Chang DW. Breast reconstruction with microvascular MS-TRAM and DIEP flaps. Arch Plast Surg 2012;39:310.

  • 123.

    Kronowitz SJ, Robb GL. Radiation therapy and breast reconstruction: a critical review of the literature. Plast Reconstr Surg 2009;124:395408.

    • Search Google Scholar
    • Export Citation
  • 124.

    Tran NV, Chang DW, Gupta A. Comparison of immediate and delayed free TRAM flap breast reconstruction in patients receiving postmastectomy radiation therapy. Plast Reconstr Surg 2001;108:7882.

    • Search Google Scholar
    • Export Citation
  • 125.

    Mehta VK, Goffinet D. Postmastectomy radiation therapy after TRAM flap breast reconstruction. Breast J 2004;10:118122.

  • 126.

    Berry T, Brooks S, Sydow N. Complication rates of radiation on tissue expander and autologous tissue breast reconstruction. Ann Surg Oncol 2010;17(Suppl 3):202210.

    • Search Google Scholar
    • Export Citation
  • 127.

    Francis SH, Ruberg RL, Stevenson KB. Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg 2009;124:17901796.

    • Search Google Scholar
    • Export Citation
  • 128.

    Colwell AS, Damjanovic B, Zahedi B. Retrospective review of 331 consecutive immediate single-stage implant reconstructions with acellular dermal matrix: indications, complications, trends, and costs. Plast Reconstr Surg 2011;128:11701178.

    • Search Google Scholar
    • Export Citation
  • 129.

    Garcia-Etienne CA, Cody Iii HS, Disa JJ. Nipple-sparing mastectomy: initial experience at the Memorial Sloan-Kettering Cancer Center and a comprehensive review of literature. Breast J 2009;15:440449.

    • Search Google Scholar
    • Export Citation
  • 130.

    Petit JY, Veronesi U, Orecchia R. Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European Institute of Oncology of Milan (EIO). Breast Cancer Res Treat 2009;117:333338.

    • Search Google Scholar
    • Export Citation
  • 131.

    Yueh JH, Houlihan MJ, Slavin SA. Nipple-sparing mastectomy: evaluation of patient satisfaction, aesthetic results, and sensation. Ann Plast Surg 2009;62:586590.

    • Search Google Scholar
    • Export Citation
  • 132.

    Chung AP, Sacchini V. Nipple-sparing mastectomy: where are we now? Surg Oncol 2008;17:261266.

  • 133.

    Gerber B, Krause A, Dieterich M. The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg 2009;249:461468.

    • Search Google Scholar
    • Export Citation
  • 134.

    Mallon P, Feron JG, Couturaud B. The role of nipple-sparing mastectomy in breast cancer: a comprehensive review of the literature. Plast Reconstr Surg 2013;131:969984.

    • Search Google Scholar
    • Export Citation
  • 135.

    Piper M, Peled AW, Foster RD. Total skin-sparing mastectomy: a systematic review of oncologic outcomes and postoperative complications [published online ahead of print March 11, 2013]. Ann Plast Surg, in press.

    • Search Google Scholar
    • Export Citation
  • 136.

    Toth BA, Forley BG, Calabria R. Retrospective study of the skin-sparing mastectomy in breast reconstruction. Plast Reconstr Surg 1999;104:7784.

    • Search Google Scholar
    • Export Citation
  • 137.

    Carlson GW, Styblo TM, Lyles RH. The use of skin sparing mastectomy in the treatment of breast cancer: the Emory experience. Surg Oncol 2003;12:265269.

    • Search Google Scholar
    • Export Citation
  • 138.

    Downes KJ, Glatt BS, Kanchwala SK. Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma. Cancer 2005;103:906913.

    • Search Google Scholar
    • Export Citation
  • 139.

    Foster RD, Esserman LJ, Anthony JP. Skin-sparing mastectomy and immediate breast reconstruction: a prospective cohort study for the treatment of advanced stages of breast carcinoma. Ann Surg Oncol 2002;9:462466.

    • Search Google Scholar
    • Export Citation
  • 140.

    Medina-Franco H, Vasconez LO, Fix RJ. Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann Surg 2002;235:814819.

    • Search Google Scholar
    • Export Citation
  • 141.

    Newman LA, Kuerer HM, Hunt KK. Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol 1998;5:620626.

    • Search Google Scholar
    • Export Citation
  • 142.

    Clough KB, Kaufman GJ, Nos C. Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery. Ann Surg Oncol 2010;17:13751391.

    • Search Google Scholar
    • Export Citation
  • 143.

    Anderson BO, Masetti R, Silverstein MJ. Oncoplastic approaches to partial mastectomy: an overview of volume-displacement techniques. Lancet Oncol 2005;6:145157.

    • Search Google Scholar
    • Export Citation
  • 144.

    Huemer GM, Schrenk P, Moser F. Oncoplastic techniques allow breast-conserving treatment in centrally located breast cancers. Plast Reconstr Surg 2007;120:390398.

    • Search Google Scholar
    • Export Citation
  • 145.

    Kaur N, Petit JY, Rietjens M. Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer. Ann Surg Oncol 2005;12:539545.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 816 501 46
PDF Downloads 222 146 18
EPUB Downloads 0 0 0